Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
oleh: Christopher J. Graber, Margaret K. Wong, Heather A. Carleton, Françoise Perdreau-Remington, Barbara L. Haller, Henry F. Chambers
| Format: | Article |
|---|---|
| Diterbitkan: | Centers for Disease Control and Prevention 2007-03-01 |
Deskripsi
We describe a case of treatment failure caused by a strain of USA300 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with intermediate susceptibility to vancomycin and reduced susceptibility to daptomycin. The strain was isolated from the bone of a 56-year-old man with lumbar osteomyelitis after a 6-week treatment course of vancomycin for catheter-associated septic thrombophlebitis.